par Seferian, Andreea Mihaela;Moraux, Amélie;Annoussamy, Mélanie;Canal, Aurélie;Decostre, Valérie;Diebate, Oumar;Le Moing, Anne-Gaelle;Gidaro, Teresa;Deconinck, Nicolas ;Van Parys, Frauke;Vereecke, Wendy;Wittevrongel, Sylvia;Mayer, Michele;Maincent, Kim;Desguerre, Isabelle;Thémar-Noel, Christine;Cuisset, Jean Marie;Tiffreau, Vincent;Denis, Severine;Jousten, Virginie;Quijano-Roy, Susana;Voit, Thomas;Hogrel, Jean-Yves;Servais, Laurent
Référence PloS one, 10, 2, page (e0113999)
Publication Publié, 2015
Référence PloS one, 10, 2, page (e0113999)
Publication Publié, 2015
Article révisé par les pairs
Résumé : | Upper limb evaluation of patients with Duchenne Muscular Dystrophy is crucially important to evaluations of efficacy of new treatments in non-ambulant patients. In patients who have lost ambulation, there are few validated and informative outcome measures. In addition, longitudinal data demonstrating sensitivity to clinical evolution of outcome measures over short-term periods are lacking. |